TLR4 Antagonism Reduces Movement-Induced Nociception and ATF-3 Expression in Experimental Osteoarthritis.

J Pain Res · 2021 · PMC8403032 · PMID 34466029

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although there was as an apparent increase in TLR4 expression in animals receiving the TLR4 antagonist (from 251.7 ± 33.4 in the OA-vehicle group to 324.7 ± 41.0 in OA-TLR4A1 animals), it did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.